MedPath

Comparison of drugs Carbetocin and Oxytocin in normal delivery wome

Phase 2
Conditions
Health Condition 1: O721- Other immediate postpartum hemorrhage
Registration Number
CTRI/2024/05/067623
Lead Sponsor
KP Salve Institute of Medical Sciences and Research Centre and Lata Mangeshkar Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Women with a singleton-term pregnancy undergoing vaginal delivery.

Exclusion Criteria

1. Hypertensive disorders in pregnancy

2. Moderate anemia (Hemoglobin less than 9gm per dl)

3. Placental abruption (determined by history and ultrasound report)

4. Placenta previa

5. Polyhydramnios

6. Grand Multipara

7. Known case of cardiac disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Quantitative measure of blood loss during the third stage of labor. <br/ ><br>2. Hemoglobin levelTimepoint: Immediately post delivery and on day 3 post delivery.
Secondary Outcome Measures
NameTimeMethod
ot applicableTimepoint: Not applicable
© Copyright 2025. All Rights Reserved by MedPath